The Regional Trials Network covers an extensive patient catchment area of approximately 141,000 km2, offering comprehensive Principal Investigator and Study Coordinator experience, trial phase 1 – 4 capabilities, accredited site facilities, and dedicated patient clinics.

The Regional Trials Network supports Teletrials with participation in the following:

  • TARGET-TP – a proactive targeted strategy for thromboembolism prevention in patients undergoing anticancer therapy.